Expert Rev Mol Diagn. 2010;10(1):49-64. With the ultimate goal of enabling personalized medicine for PC, massive efforts have been undertaken to identify new and better diagnostic, prognostic and ...
Science is not shy about ambiguity, never more so than when it comes to medical advice. So here’s the latest recommendation on prostate-cancer screening: Men should continue to have both a manual ...
The core foundation of precision medicine, and in turn, precision oncology, is a personalized approach to treatment that focuses on targeting specific molecular features that impact how cancer cells ...
Survivin is considered as a cancer therapeutic target as aberrant high expression of survivin was documented in many different types of human cancer. 10 It is thought that survivin overexpression ...
Patients with prostate cancer who received androgen deprivation therapy prior to prostatectomy had lower levels of hypoxia inducible factor 1a, and higher expression of VEGF-A and VEGF-C was ...
A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its market-leading Decipher Prostate Genomic Classifier is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback